VEGFR2/CD309 抗体 (AA 31-130)
Our Local Distributor
北京 101111
Quick Overview for VEGFR2/CD309 抗体 (AA 31-130) (ABIN517318)
抗原
See all VEGFR2/CD309 (VEGFR2) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 31-130
-
原理
- Mouse monoclonal antibody raised against a partial recombinant KDR.
-
序列
- LPRLSIQKDI LTIKANTTLQ ITCRGQRDLD WLWPNNQSGS EQRVEVTECS DGLFCKTLTI PKVIGNDTGA YKCFYRETDL ASVIYVYVQD YRSPFIASVS
-
交叉反应
- 人
-
产品特性
- Antibody Reactive Against Recombinant Protein.
-
免疫原
- KDR (NP_002244, 31 a.a. ~ 130 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
亚型
- IgG2a
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
缓冲液
- In 1x PBS, pH 7.4
-
注意事项
- Aliquot to avoid repeated freezing and thawing.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
别名
- KDR
-
背景
-
Full Gene Name: kinase insert domain receptor (a type III receptor tyrosine kinase)
Synonyms: CD309,FLK1,VEGFR,VEGFR2 -
基因ID
- 3791
-
NCBI登录号
- NM_002253
-
途径
- RTK signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
抗原
-